Literature DB >> 8871394

Fentanyl patches left on dead bodies -- potential source of drug for abusers.

L M Flannagan1, J D Butts, W H Anderson.   

Abstract

We report a fatal case of fentanyl poisoning in which the decedent apparently obtained the drug from a used transdermal patch removed from a deceased nursing home patient. Fentanyl drug patches, even those previously used, contain a potentially lethal amount of this potent narcotic analgesic and provide a source of fentanyl for drug abusers. This case demonstrates the importance of proper disposal of these drug patches and the need for strict policies and guidelines in patient care settings regarding their disposal. Since fentanyl derivatives may not be detected on routine toxicologic analysis, specific assays should be utilized for the detection of fentanyl in cases of suspected drug overdose.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871394

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  7 in total

1.  [Accidental intoxication with unlabeled, generic transdermal fentanyl patches caused by insufficient instruction].

Authors:  S Tank; K Stork; W Skibba; S Zittel; H Andresen; A E Goetz; H Beck
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

2.  Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.

Authors:  Stephen L Thornton; Micheal A Darracq
Journal:  J Med Toxicol       Date:  2019-08-13

Review 3.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 4.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12

5.  The afterlife of drugs and the role of pharmEcovigilance.

Authors:  Christian G Daughton; Ilene Sue Ruhoy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 6.  Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.

Authors:  Craig A Kornick; Juan Santiago-Palma; Natalia Moryl; Richard Payne; Eugenie A M T Obbens
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  The Laboratory's Role in Opioid Pain Medication Monitoring.

Authors:  Geza S Bodor
Journal:  EJIFCC       Date:  2012-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.